Will Investors Resuscitate These Beaten-Down Biotech Stocks?

The Life Sciences Report | |

The list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who

14 Small-Cap Biotech Stocks to Consider After the Pullback

The Life Sciences Report | |

It's been four months since The Life Sciences Report's 2015 Small-Cap Biotech Watchlist was announced at the Biotech Showcase in San Francisco. The year is off to a bumpy start, though the

Analysts: Small-Cap Biotech Stocks Investors Need to Know Now

The Life Sciences Report | |

At the Biotech Showcase 2015 in San Francisco, five biotech analysts examined the burgeoning small-cap life sciences marketplace and found every reason to believe its good health would continue

Where to Look for Biotech Bargains

The Life Sciences Report | |

Every business day, Edison Investment Research Analyst Pooya Hemami scours the global markets for life science companies with upside flowing through their product pipelines. In this interview with

Can-Fite BioPharma Rings The Opening Bell at NYSE

Can-Fite Biopharma Ltd - $CANF | |

On Dec. 5, Can-Fite BioPharma (CANF)  celebrated rang the Opening Bell at the New York Stock Exchange to celebrate the Petach Tikva, Israel-based company's recent listing on the

Wall Street Blues as Stocks Erase Early Gains to End Lower

Michael Teague | |

Stocks retreated from early gains in afternoon trading on Tuesday, handing Wall Street its second consecutive day of losses ahead of a much anticipated speech from Fed Chairman Ben Bernanke. The

Can-Fite BioPharma: A Cut Above Small-Cap Drug Manufacturers

Spotlight Companies | |

The enthusiasm that accompanied bull market conditions through the first half of 2013 has by now been tempered by a wide array of variables: uncertain global economic conditions, the apparent

Discover: Trending Events

United Nations
EU Parliament
Humanity 2.0
World Economic Forum